Helms v. Monsanto Co.

558 F. Supp. 928, 1982 U.S. Dist. LEXIS 9971
CourtDistrict Court, N.D. Alabama
DecidedNovember 29, 1982
DocketCV 82-L-5141-NE
StatusPublished
Cited by4 cases

This text of 558 F. Supp. 928 (Helms v. Monsanto Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Helms v. Monsanto Co., 558 F. Supp. 928, 1982 U.S. Dist. LEXIS 9971 (N.D. Ala. 1982).

Opinion

MEMORANDUM OF OPINION

LYNNE, Senior District Judge.

This is an action by Clark Ray Helms for Declaratory Judgment claiming that defendant, Monsanto Company, Helms’ employer, wrongfully denied him total and permanent disability benefits. The disability benefits plaintiff seeks are provided by *929 Monsanto Company’s Disability Income Plan (“DIP”). DIP is an employee welfare benefit plan as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. 1002(1). Thus, the provisions of ERISA control this case.

DIP provides benefits to Monsanto employees who are totally and temporarily disabled and those who are totally and permanently disabled. According to DIP:

“Total and Permanent Disability”

An eligible employe shall be deemed to be Totally and Permanently Disabled only when and during the period that it is determined by the Corporation’s Department of Medicine and Environmental Health solely on the basis of medical evidence furnished to the Corporation from time to time that: 1) he is totally disabled and continues to be totally disabled by reason of bodily injury or disease so as to be prevented thereby from engaging in any occupation or employment for remuneration or profit (as determined by the Corporation); 2) his condition of disability has existed continuously for not less than six consecutive months; and 3) his condition of total disability is presumed to be permanent during the remainder of his life. It must also be determined that 1) his condition of total disability did not result from i) any service for another employer, including service in the Armed Forces of any country, or from activity other than employment with the Employer pursued for remuneration or profit on a full-time, part-time, temporary or permanent basis; ii) warfare or acts of the public enemy; iii) participation in any criminal or unlawful act; or iv) willful misconduct; and 2) he has not attained his 65th birthday.

In May, 1980, plaintiff submitted to Monsanto his “Statement of Claim for Disability Benefits” as provided in DIP, claiming that as a result of retinitis pigmentosa he was totally and permanently disabled within the terms of DIP and therefore entitled to benefits under the Plan. Upon receipt of plaintiff’s claim, the Employee Benefits Plan Committee (“EBPC”), which administers DIP, referred the matter to Monsanto’s medical department. After examining plaintiff and reviewing reports from several of plaintiff’s doctors, the Monsanto medical department found that plaintiff was not totally and permanently disabled within the Plan definition. Helms did not agree. DIP prescribes the procedure to be followed when an employee and the Company disagree on whether the employee is disabled. DIP provides:

In the event of an unresolved disagreement between the Corporation and an employe as to whether the employe is Totally and Permanently Disabled, the employe shall be examined by the licensed medical practitioner or practitioners jointly selected by the Corporation and the employe, and the decision of such licensed medical practitioner or practitioners so jointly selected shall be binding on the Corporation and the employe. The fees and expenses of the medical practitioner or practitioners so jointly selected shall be shared equally by the Corporation and the employe. Before making a decision, the medical practitioner or practitioners so jointly selected may consult and confer with the medical practitioners who previously examined the employe at his request or at the Corporation’s request. No such examination and determination shall be made more often than semi-annually.

In accordance with the Plan, Monsanto and plaintiff jointly selected a third-party medical expert, Dr. Harold Skalka, to arbitrate their differences regarding the extent of plaintiff’s disability. Dr. Skalka is a board certified ophthalmologist and presently is a professor and chairman of the Department of Ophthalmology at the Eye Foundation Hospital associated with the Medical School of the University of Alabama. Pursuant to the terms of the Plan, Helms and Monsanto agreed that Skalka’s decision would be binding on both of them. On February 18,1982, Dr. Skalka examined plaintiff for approximately two hours and reviewed the medical reports of other doc *930 tors who had examined him. Dr. Skalka concluded that plaintiff indeed had retinitis pigmentosa 1 and that he was disabled from performing any occupation requiring significant visual acuity. Dr. Skalka further concluded, however, that Helms was not totally and permanently disabled from engaging in any occupation for remuneration or profit and therefore did not meet the DIP definition of disability. Monsanto, on the basis of Dr. Skalka’s decision, denied plaintiff’s claims for disability benefits.

This case presents two questions for the Court’s consideration. First, is the procedure by which the parties delegate the decision-making function to Dr. Skalka somehow improper under ERISA? Second, was Dr. Skalka’s decision that plaintiff was not totally and permanently disabled arbitrary and capricious so that plaintiff can avoid the binding effect of the third-party arbitrator’s decision. 2 This Court answers both questions in the negative.

Section 503 of ERISA requires that each ERISA plan provide a claims procedure that affords a participant with a full and fair review of a decision denying him benefits. This court holds that the procedure prescribed by DIP adequately provides for such a full and fair review. First, the Labor Department’s ERISA regulations make clear that the fiduciary, in this case EBPC, may designate a person to review a participant’s denied claim. 29 C.F.R. § 2560.503-1(g)(1). Second, nothing in ER-ISA expressly prohibits such a delegation. Third, such a delegation is not inconsistent with the policies underlying ERISA. A participant can receive a full and fair review of his denied claim from a person designated by the EBPC, especially when the plan participant participates in the selection of such person as in this case. The Plan’s fiduciaries and this Court are bound by the language of DIP unless the provision in question is clearly inconsistent with the policies underlying ERISA. Blackmar v. Lichtenstein, 603 F.2d 1306 (6th Cir.1980); Flinchbangh v. Chicago Pneumatic Tool Co., 531 F.Supp. 110 (W.D.Pa.1982). Thus, the designation of a third-party expert such as Dr. Skalka is not an improper delegation of the EBPC’s fiduciary duties. .Another federal court has reached the same conclusion. Sample v. Monsanto, 485 F.Supp. 1018 (E.D.Mo.1980). In Sample the court ruled:

[T]he medical arbitration procedures are a reasonable delegation of defendant’s [Monsanto’s] fiduciary duties under the plan.

485 F.Supp. at 1019. This Court agrees.

To the extent Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Tom
558 F. Supp. 2d 942 (D. Minnesota, 2008)
Marta J. Osimowicz v. Ford Motor Company
9 F.3d 109 (Sixth Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
558 F. Supp. 928, 1982 U.S. Dist. LEXIS 9971, Counsel Stack Legal Research, https://law.counselstack.com/opinion/helms-v-monsanto-co-alnd-1982.